Immutep Limited (IMMP) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
IMMP Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 9, 2026, Immutep Limited (IMMP) trades at a price-to-earnings ratio of -1.5x, with a stock price of $0.45 and trailing twelve-month earnings per share of $-0.71.
Compared to the Healthcare sector median P/E of 21.9x, IMMP trades at a 107% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 176.0x.
Relative to the broader market, IMMP trades at a notable discount to the S&P 500 median P/E of 24.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our IMMP DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
IMMP P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $234M | 4.7Lowest | 4.67 | +49% | |
| $115B | 16.3 | - | +178%Best | |
| $275B | 15.3 | 0.72 | +8% | |
| $74B | 17.2 | 2.72 | +8% | |
| $12B | 17.3 | 0.34Best | +58% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See IMMP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IMMP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IMMP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIMMP — Frequently Asked Questions
Quick answers to the most common questions about buying IMMP stock.
Is IMMP stock overvalued or undervalued?
IMMP current P/E: -1.5x. 5-year average P/E: N/A. Percentile: N/A.
How does IMMP's valuation compare to peers?
Immutep Limited P/E of -1.5x compares to sector median of 21.9x. The discount suggests lower growth expectations or higher risk.
What is IMMP's PEG ratio?
IMMP PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.